Hendry S, Salgado R, Gevaert T et al (2017) Assessing tumor-infiltrating lymphocytes in solid tumors: a practical review for pathologists and proposal for a standardized method from the International Immuno-Oncology Biomarkers Working Group: part 2: TILs in melanoma, gastrointestinal tract carcinomas, non-small cell lung carcinoma and mesothelioma, endometrial and ovarian carcinomas, squamous cell carcinoma of the head and neck, genitourinary carcinomas, and primary brain tumours. Adv AnatPathol 24:311–335

Google Scholar 

Fuchs TL, Sioson L, Sheen A, Jafari-Nejad K, Renaud CJ, Andrici J, Ahadi M, Chou A, Gill AJ (2020) Assessment of tumor-infiltrating lymphocytes using International TILs Working Group (ITWG) system is a strong predictor of overall survival in colorectal carcinoma: a study of 1034 patients. Am J SurgPathol 44(4):536–544

Article  Google Scholar 

Khoury T, Nagrale V, Opyrchal M, Peng X, Wang D, Yao S (2018) Prognostic significance of stromal versus intratumoral infiltrating lymphocytes in different subtypes of breast cancer treated with cytotoxic neoadjuvant chemotherapy. Appl Immunohistochem Mol Morphol 2(8):523–532

Article  Google Scholar 

Salgado R, Denkert C, Demaria S, Sirtaine N, Klauschen F, Pruneri G et al (2015) The evaluation of tumorinfiltrating lymphocytes (TILs) in breast cancer: recommendations by an international TILs working group 2014. Ann Oncol 26:25971

Article  Google Scholar 

Aboelnasr LS, El-Rebey HS, Mohamed A, Abdou AG (2022) The prognostic impact of tumor border configuration, tumor budding and tumor stroma ratio in colorectal carcinoma. Turk PatolojiDerg, https://doi.org/10.5146/tjpath.2022.01579

Jass JR, Ajioka Y, Allen JP, Chan YF, Cohen RJ, Nixon JM, Radojkovic M, Restall AP, Stables SR, Zwi LJ (1996) Assessment of invasive growth pattern and lymphocytic infiltration in colorectal cancer. Histopathology 28:543–548

Article  CAS  PubMed  Google Scholar 

Lugli A, Kirsch R, Ajioka Y, Bosman F, Cathomas G, Dawson H et al (2017) Recommendations for reporting tumor budding in colorectal cancer based on the International Tumor Budding Consensus Conference (ITBCC) 2016. Mod Pathol 30(9):1299–1311

Article  PubMed  Google Scholar 

Loughrey M, Quirke P, Shepherd NA (2018) G049 Dataset for histopathological reporting of colorectal cancer. R Coll Pathol September 108:1–62

Google Scholar 

Wu J, Liang C, Chen M, Su W (2016) Association between tumor-stroma ratio and prognosis in solid tumor patients: a systematic review and meta-analysis. Oncotarget 7:68954–68965

Article  PubMed  PubMed Central  Google Scholar 

van Pelt GW, Kjær-Frifeldt S, van Krieken JHJM, Al Dieri R, Morreau H, Tollenaar RAEM, Sørensen FB, Mesker WE (2018) Scoring the tumor-stroma ratio in colon cancer: procedure and recommendations. Virchows Arch 473:405–412

Article  PubMed  PubMed Central  Google Scholar 

Huijbers A, Tollenaar RAEM, Pelt GW, Zeestraten ECM, Dutton S, McConkey CC, Domingo E, Smit VTHBM, Midgley R, Warren BF, Johnstone EC, Kerr DJ, Mesker WE (2013) The proportion of tumor-stroma as a strong prognosticator for stage II and III colon cancer patients: validation in the VICTOR trial. Ann Oncol 24:179–85

Article  CAS  PubMed  Google Scholar 

Jakubowska K, Koda M, Kisielewski W, Kańczuga-Koda L, Famulski W (2019) Tumor-infiltrating lymphocytes in primary tumors of colorectal cancer and their metastases. Exp Ther Med 18(6):4904–4912

CAS  PubMed  PubMed Central  Google Scholar 

Román R, Verdú M, Calvo M, Vidal A, Sanjuan X, Jimeno M, Salas A, Autonell J, Trias I, González M, García B, Rodón N, Puig X (2010) Microsatellite instability of the colorectal carcinoma can be predicted in the conventional pathologic examination. A prospective multicentric study and the statistical analysis of 615 cases consolidate our previously proposed logistic regression model. Virchows Arch 456:533–41

Article  PubMed  Google Scholar 

Vitorino M, Eiriz I, Tomás TC et al (2022) Association of tumor-infiltrating lymphocytes with survival in stages II and III colorectal cancer. Cureus 14(11):e31144

PubMed  PubMed Central  Google Scholar 

Sadek SA, Rehim DM, Fatima S (2020) The role of tumor budding in colorectal adenocarcinoma: possible involvement of the intestinal cancer stem cell marker Lgr5. Indian J Pathol Microbiol 63(1):32–37

Article  PubMed  Google Scholar 

De Smedt L, Palmans S, Andel D, Govaere O, Boeckx B, Smeets D, Galle E, Wouters J, Barras D, Suffiotti M, Dekervel J, Tousseyn T, De Hertogh G, Prenen H, Tejpar S, Lambrechts D, Sagaert X (2017) Expression profiling of budding cells in colorectal cancer reveals an EMT-like phenotype and molecular subtype switching. Br J Cancer 116:58–65

Article  PubMed  Google Scholar 

Graham RP, Vierkant RA, Tillmans LS, Wang AH, Laird PW, Weisenberger DJ, Lynch CF, French AJ, Slager SL, Raissian Y, Garcia JJ, Kerr SE, Lee HE, Thibodeau SN, Cerhan JR, Limburg PJ, Smyrk TC (2015) Tumor budding in colorectal carcinoma: confirmation of prognostic significance and histologic cutoff in a population-based cohort. Am J Surg Pathol 39(10):1340–1346

Article  PubMed  PubMed Central  Google Scholar 

Park JH, Richards CH, McMillan DC, Horgan PG, Roxburgh SD (2014) The relationship between tumour stroma percentage, the tumour microenvironment and survival in patients with primary operable colorectal cancer. Ann Oncol 25:644–651

Article  CAS  PubMed  PubMed Central  Google Scholar 

Eriksen AC, Sørensen FB, Lindebjerg J, Hager H, dePont C, René KF, Sanne H, Torben F (2018) The prognostic value of tumour stroma ratio and tumour budding in stage II colon cancer. A nationwide population-based study. Int J Colorectal Dis 33:1115–24

Article  PubMed  PubMed Central  Google Scholar 

Kalluri R (2016) The biology and function of fibroblasts in cancer. Nat Rev Cancer 16:582–598

Article  CAS  PubMed  Google Scholar 

Hujibers, Mesker WE, Liefers GJ, Junggeburt JM et al (2009) Presence of a high amount of stroma and downregulation of SMAD4 predict for worse survival for stage I-II colon cancer patients. Cell Oncol 31:169–178

Google Scholar 

Mesker WE, Liefers GJ, Junggeburt JM, van Pelt GW, Alberici P, Kuppen PJ, Miranda NF, van Leeuwen KA, Morreau H, Szuhai K, Tollenaar RA, Tanke HJ (2009) Presence of a high amount of stroma and downregulation of SMAD4 predict for worse survival for stage I-II colon cancer patients. Cell Oncol 31(3):169–178. https://doi.org/10.3233/CLO-2009-0478

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mesker WE, Junggeburt JM, Szuhai K, de Heer P, Morreau H, Tanke HJ, Tollenaar RA (2007) The carcinoma-stromal ratio of colon carcinoma is an independent factor for survival compared to lymph node status and tumor stage. Cell Oncol 29(5):387–398. https://doi.org/10.1155/2007/175276

Article  PubMed  PubMed Central  Google Scholar 

Demir A, Alan O, Oruc E (2019) Tumor budding for predicting prognosis of resected rectum cancer after neoadjuvant treatment. World J Surg Oncol 17(1):50

Article  PubMed  PubMed Central  Google Scholar